Rinvoq ER 45 MG tablet UU 28S
Ended Awarded
- Contract number
- SPE2DB25FWKET
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,113
Award facts
- Contract value 100% obligated
- $30,112.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $30,112.89 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 45 MG tablets (quantity 28 units) on August 22, 2025, with an ultimate completion date of August 25, 2025. This delivery order represents a non-set-aside, competitively awarded contract with performance at the contractor's facility in Conshohocken, Pennsylvania. The award is classified as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026, which serves as a comprehensive pharmaceutical supply vehicle for military healthcare systems worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly through the Defense Logistics Agency's Medical Supply Chain. The company's contract portfolio with the DLA encompasses a broad range of pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order for RINVOQ ER tablets supports the DLA's mission to provide pharmaceutical commodities to military healthcare programs and demonstrates the contractor's continued capability to fulfill federal medical supply requirements through competitive procurement.
Quick answers
Who was awarded contract SPE2DB25FWKET?
SPE2DB25FWKET was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 22, 2025.
How much is contract SPE2DB25FWKET worth?
The government has obligated $30,113 on SPE2DB25FWKET.
Is contract SPE2DB25FWKET an order under another contract?
Yes. SPE2DB25FWKET is a delivery order under SPE2DB25D3020, an indefinite delivery contract.
Was contract SPE2DB25FWKET competed?
The extent of competition for SPE2DB25FWKET was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award